At Cytel, our global advanced HEOR and RWE teams turn evidence into action, generating insights that complement clinical trials, support policy and access decisions, accelerate submissions, expand indications, and demonstrate value, and ultimately, driving meaningful patient impact.

On May 17–20, our experts in HEOR, Market Access, and RWE will be present at ISPOR US. Visit us at booth #1039 to learn more about our innovative offerings.

Make sure to mark our Cytel poster presentations and speaking slots in your calendar:

• Prompt Engineering for HEOR: Practical Skills and Use Cases for HEOR Professionals (Short course by Dalia Dawoud): May 17, 8AM – 12PM
• Living HTA in the Age of AI Innovation: Supporting HTA Decisions at the Speed of Evolving Evidence (Forum with Dalia Dawoud and Grammati Sarri): May 18, 12:15PM – 1:15PM
• Global Value Frameworks: Aligning HEOR, Access and Policy Across Borders (Forum with Dalia Dawoud): May 18; 3:15PM – 4:15PM
• A Pilot Assessment of LLM-Generated Synthetic Cohorts: A First Step Toward Robust Synthetic Control Arms (Poster by Manuel Cossio, Anu Vasudevan, and Deepa Jahagirdar): May 18, 4PM – 7PM
• Accelerating Dynamic HTA Landscaping in Oncology Through Autonomous Generative AI-Driven Multilingual Data Extraction (Poster by Manuel Cossio and Lilia Leisle): May 18, 4PM – 7PM

We hope to see you in Philadelphia!